Andere talen Race Oncology Limited

Aandelen

RAC

AU000000RAC3

Beurs gesloten - Australian S.E. Andere beurzen 08:10:13 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,825 ^AUD	+1,11%		-0,82%	+117,26%

20/06	Race Oncology stelt George Clinical aan voor RC220 Bisantrene Fase 1 Studie	MT
18/06	Race Oncology ontvangt aanwijzing zeldzame kinderziekte van de Amerikaanse FDA voor leukemiemedicijn	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Race Oncology Concludes GLP Non-clinical Toxicology and Safety Pharmacology Studies for RC220 Bisantrene; Shares Jump 10%	26/06
Race Oncology Appoints George Clinical for RC220 Bisantrene Phase 1 Trial	20/06
Race Oncology Receives US FDA Rare Pediatric Disease Designation for Leukemia Medication	18/06
Race Oncology Validates Efficacy of Blood Cancer Therapy in Animal Study; Shares Rise 6%	13/06
Race Oncology Secures US FDA Orphan Drug Designation for Leukemia Medication; Shares Rise 5%	11/06
Race Oncology's breakthrough in cancer cell treatment	15/05
Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6%	26/03
Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index	18/03
Race Oncology Says Study Shows Lead Asset's Efficacy in Blood Cancer Treatment	06/03
Race Oncology looks to accelerate clinical development of bisantrene	28/02
Race Oncology Widens Loss in Fiscal H1	28/02
Race Oncology Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
Race Oncology appoints Dr Daniel Tillett as CEO	23/11
Race Oncology Names CEO; Shares Jump 5%	22/11
Race Oncology Limited Appoints Daniel Tillett as Chief Executive Officer	21/11
Race Oncology highlights impressive bisantrene clinical data	07/11
Race Oncology kicks off safety studies for RC220	09-10-23
Race Oncology Initiates Toxicology, Safety Pharmacology Studies of Chemotherapy Drug	05-10-23
Race Oncology Limited(ASX:RAC) dropped from S&P Global BMI Index	18-09-23
Race Oncology Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Race Oncology Limited

Aandelen

RAC

AU000000RAC3

Andere talen

Filters